Literature DB >> 20214539

Ante- and post-mortem diagnosis of rabies using nucleic acid-amplification tests.

Supaporn Wacharapluesadee1, Thiravat Hemachudha.   

Abstract

Sensitivity, specificity and short turn-around time nucleic acid-amplification tests (NATs) have been steadily improving. NATs have been employed in the diagnosis of rabies to distinct different strains, as well as to identify new lyssaviruses. NATs have advantages over traditional methods, such as the direct fluorescence antibody test. They can be applied to fluid samples and brain tissue that is substantially decomposed. NATs can be used as an alternative method for confirmation or exclusion of the diagnosis in a suspected rabies patient. Real-time PCR methods are more favored than conventional reverse-transcription PCR methods by several laboratories. Second-round PCR, either nested or heminested, has been used for ante-mortem diagnosis to detect low levels of RNA. This review the details obstacles in making a diagnosis, how to properly utilize NATs (sample preparation, nucleic amplification techniques, amplification targets and primer design); and interprets the results obtained in recent studies.

Entities:  

Mesh:

Year:  2010        PMID: 20214539     DOI: 10.1586/erm.09.85

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  18 in total

1.  Improved PCR methods for detection of African rabies and rabies-related lyssaviruses.

Authors:  Jessica Coertse; Jacqueline Weyer; Louis H Nel; Wanda Markotter
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

2.  Molecular epidemiology of rabies virus circulating in domestic animals in India.

Authors:  Gundallhalli Bayyappa Manjunatha Reddy; Sumana Krishnappa; Balamurugan Vinayagamurthy; Rajendra Singh; Karam Pal Singh; Mani Saminathan; Basavaraj Sajjanar; Habibur Rahman
Journal:  Virusdisease       Date:  2018-07-17

Review 3.  Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Authors:  Anita Mahadevan; M S Suja; Reeta S Mani; Susarala K Shankar
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Comparative analysis of rabies virus reverse transcription-PCR and virus isolation using samples from a patient infected with rabies virus.

Authors:  Marcus Panning; Sigrid Baumgarte; Susanne Pfefferle; Tanja Maier; Andreas Martens; Christian Drosten
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

5.  Lyssavirus detection and typing using pyrosequencing.

Authors:  Paola De Benedictis; Cristian De Battisti; Laurent Dacheux; Sabrina Marciano; Silvia Ormelli; Angela Salomoni; Silvia Tiozzo Caenazzo; Anthony Lepelletier; Hervé Bourhy; Ilaria Capua; Giovanni Cattoli
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

Review 6.  More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques.

Authors:  Laurent Dacheux; Supaporn Wacharapluesadee; Thiravat Hemachudha; François-Xavier Meslin; Philippe Buchy; Jean-Marc Reynes; Hervé Bourhy
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

7.  Role of the RT-PCR method in ante-mortem & post-mortem rabies diagnosis.

Authors:  Dan David
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

8.  Real-Time RT-PCR for the Detection of Lyssavirus Species.

Authors:  A Deubelbeiss; M-L Zahno; M Zanoni; D Bruegger; R Zanoni
Journal:  J Vet Med       Date:  2014-10-16

9.  Comparison of biotinylated monoclonal and polyclonal antibodies in an evaluation of a direct rapid immunohistochemical test for the routine diagnosis of rabies in southern Africa.

Authors:  Andre Coetzer; Claude T Sabeta; Wanda Markotter; Charles E Rupprecht; Louis H Nel
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

10.  Simultaneous detection and differentiation of human papillomavirus genotypes 6, 11, 16 and 18 by AllGlo quadruplex quantitative PCR.

Authors:  Daojun Yu; Yu Chen; Shenghai Wu; Baohong Wang; Yi-Wei Tang; Lanjuan Li
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.